Ubamatamab | Interleukin Related interleukin-related.com

Product Name :
Ubamatamab

Search keywords :
Ubamatamab

drugId :
null

Target Vo:
Mucin-16

Target Vo Short Name :
MUC16

Moa_Name:
Mucin-16 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Regeneron Pharmaceuticals Inc

Active Indication_Name:
Peritoneal Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Hsp27 (Ser78) Antibody
Phospho-c-Myc (Ser62) Antibody
CYP11A1 Antibody: CYP11A1 Antibody is an unconjugated, approximately 53/57 kDa, rabbit-derived, anti-CYP11A1 polyclonal antibody. CYP11A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts